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Immunologic mechanisms  involved in  homograft  rejection and  tuberculin 
sensitivity have been suggested to be similar modalities of delayed sensitivity 
(1). Cogent evidence for this proposed similarity has been the consistent finding 
of the essentiality of the lymphoid cell in the passive transfer of both of these 
reactions (2). In tuberculin sensitivity, significant numbers of sensitized lymph- 
oid cells have been shown to accumulate at the site of the tuberculin skin test 
following passive  intravenous  transfer  of  labeled  sensitized  ceils.  Sensitized 
lymphoid cells did not accumulate at the injection site of non-specific antigen 
nor were non-sensitized cells attracted to the site of PPD application (3). In 
addition, BCG-sensitized cells enclosed in millipore chambers were found to be 
ineffective in the transfer of tuberculin sensitivity (4). 
This  study  was  designed  to  examine  the  skin  homograft  site  after  cells, 
labeled with tritiated thymidine and sensitized to the homologous skin donor, 
were passively transferred to homografted isologons hosts. With this technique, 
the number, types, and distribution of sensitized cells could be ascertained in 
the rejection site. In addition, the ability of sensitized cells to destroy a homo- 
graft at a distance was studied by transferring transplantation immunity with 
sensitized qells  enclosed in millipore chambers impermeable to the passage of 
cells. 
Materials  and  Methods 
I.  Tritiated Lymphoid Cells.-- 
Two inbred strains of mice, A and CBA,  l were used throughout the study. All skin grafts 
were prepared as full thickness grafts. The panniculus adiposus and panniculus carnosus were 
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1  2  C3H  mice were used  as  donors of  skin for  some controls in  the  millipore 
chamber transfers. 
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removed from the under surface of the dermis by sharp dissection. The grafts were fitted 
orthotopicaliy into recipient beds and held in place  with either interrupted or continuous 
5-0 silk sutures. The sensitizing skin grafts were cut into equilateral triangles measuring 2 cm 
on each side and placed on recipients with the apex of the graft in the nuchal region and the 
base crossing the scapulae.  This arrangement permitted harvesting of sensitized cells from 
regional cervical and axillary lymph nodes of prospective donor mice. The test skin grafts 
were cut into rectangles measuring 1 by 2 cm and were sutured into defects over the lumbar 
area of the back, thus permitting removal of both the graft and the graft bed at the time of 
biopsy. Both the sensitizing grafts and the test grafts were handled under sterile conditions 
and were not covered by dressing after placement. The recipient mice were isolated in in- 
dividual cages and were thus prevented from disturbing each other's grafts, and by virtue of 
the position of the grafts from disturbing their own. 
Donor mice of each strain were sensitized to the homologous strain by cross-skin grafts 
and intraperitoneal injection of 107 spleen cells,  two days after grafting. The donor mice were 
injected intraperitoneally with 0.25 ~c of tritiated thymidine per gm of body weight every 8 
hours for 3 days prior to cell transfer. 8 hours after the last isotope injection, 9  days after 
TABLE  I 
The Differential  Counts and Per Cent of Labelled Cells in the Cell Transfer  Suspensions 
Per cent of total  Per cent cell type  Per cent cell type 
Mononttclear cell type  Cells*  labeled  of total labeled cells 
Small,  <8~ ........................  48  24  36 
Medium, 8 to 12 ~ ..................  42  39  48 
Large,  >  12 ~ .....................  9  58  16 
* The  remaining  1  per  cent  includes  polymorphonuclear leukocytes,  megakaryocytes, 
and other unidentified cell types. 
grafting, the cervical and axillary  lymph nodes and spleens were removed and shredded with 
rakes in balanced salt solution (Hanks') containing 20 per cent PVP by volume. The resulting 
suspension was passed through an 80 gauge monel gauze filter. Smears were made for differ- 
ential analysis and autoradiography. Total numbers were determined in a  hemocytometer, 
and cell viability was measured by staining with 1:1000 trypan blue. 
An average of 38 per cent of the cells in suspension were labeled. In Table I are shown the 
differential counts of the mononuclear cells, the percentage of each cell type labeled, and the 
proportion of each cell type labeled within the total number of tritiated elements. Over 90 
per cent of the transferred cells were viable as indicated by the trypan blue staining technique. 
The lymphoid cell suspensions were injected into the recipient mice in doses ranging from 
two to six lymphoid equivalents,  s Transfer of cells was achieved by intravenous or a combina- 
tion of  intravenous and  intraperitoneal administration to  A  mice  and  by  intraperitoneai 
administration to CBA mice. When the intravenous route was used only 2 lymphoid equiva- 
lents were given since higher doses resulted in prohibitively elevated mortality rates in the 
recipients. When the intraperitoneal route was used the residual cellular brei was included 
in the transfer along with the cell suspension. 
To  investigate different combinations of  duration of  cell transfer and  duration of  skin 
2 A lymphoid equivalent is the number of regional lymph node and spleen ceils obtained 
from a single donor mouse, and in this experiment ranged between 160 and 240 X  10  e lymph- 
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grafting,  test  skin  homografts  were  placed on  isologous  recipients  from 3 days  before  to  3 days 
after  the transfer  of sensitized  cells.  The recipient  mice were then sacrificed  at daily  intervals 
up to 6 days after  skin grafting.  The test  graft  sites  and also  the spleens,  lymph nodes, and 
other pertinent organs were processed for histology  and autoradiography. 
In a series  of 6 animals,  sensitized  labeled  lymph nodes removed 9 days after  skin  grafting 
were sliced  into  small  fragments  and placed subcutaneously around skin  homografts  on recipi- 
ent  isologous  mice.  Skin  graft  sites,  lymph nodes,  and  spleens  were  removed from  these  animals 
at daily  intervals  up to 6 days for histology  and autoradiography. 
For histology,  tissues  were stained  with hematoxylln and eosin.  For autoradiography, the 
unstained tissues  and smears were coated with liquid  Kodak NTB-2 or NTB-3 track emul- 
sions.  After 18, 30, and 60 day exposure periods,  the autoradiographs were developed and 
tissue  sections  were stained  with hematoxyliu and smears with Azure B bromide. 
II. Lymphoid Cells  in  Millipore  Chambers.- 
Suspensions  of sensitized  lymph node and spleen  cells,  without isotopic  labeling,  were 
prepared in  the  same  manner  from  donor  A and CBA mice  as  described  above.  The suspensions, 
including  tissue  brei,  were placed in millipore  chambers 13 mm  in diameter with VC  ~ mem- 
branes having a pore size  of  0.I~ and a thickness  of 150/~.  These chambers were constructed 
by attaching the VC membrane to a lucite  ring  (13 mm  in diameter, 2 mm  wide and 2 mm 
thick) using MF a cement, formulation No. I, to obtain a quick-drying bond between the 
membcane and the lucite  ring.  The incite  ring  and attached membrane were  sterilized  in  1  :  750 
aqueous zephiran chloride  4 and rinsed  in sterile  saline.  Each chamber was found to hold ap- 
proximately one lymphoid equivalent in an 0.i ml volume. After the cell  suspension was 
placed in the chamber with  a sterile  syringe,  the chamber was sealed  by  attaching  a second 13 
mm  VC filter  to the open end of the lucite  ring  with MF  cement. The filled  chambers were 
immersed in balanced salt  solution  containing 20 per cent PVP by volume and i00,000 units 
aqueous peuicillin  per ml in preparation for transfer  to recipient  mice. The time lapse  from 
removal  of  the lymph nodes  and spleens  to  insertion  of  the millipore  chambers never  exceeded 
90 minutes. 
The recipient  isologous  mice were divided into  two experimental groups. In the first  group 
of 30 mice, two or three millipore  chambers containing sensitized  cells  were placed in the 
peritoneal  cavity.  Homologous skin grafts  were applied to the dorsa of these recipients  two 
days later.  In the second group of  36 animals, three  or  four  millipore  chambers were placed 
subcutaneously around  the periphery  of  the graft  bed and the test  homograft was sutured into 
place.  The skin grafts  from both groups were biopsied at 3 and 6 days after  grafting and 
sections  were taken  for  histology. 
For controls,  miUipore chambers containing non-sensitlzed  isologous  lymphoid cells  were 
placed in the peritoneal  space of 16 mice and subcutaneously around homografts of  skin  in 26 
mice. The mice with intraperitoneal  chambers with skin homografted 2 days later.  Biopsies 
were obtained for histology  from both groups 6 days after  skin grafting. 
In  6 CB  A mice  withintraperitoneal  millipore  chambers  containing  cells  sensitized  t  o  A tissues 
a C3H skin graft  was applied  in addition  to the A skin graft.  This control  was used to deter- 
mine the specificity  of the effect  observed on skin homografts by cells  sensitized  to the ho- 
mologous donor and enclosed  in rnlllipore  chambers. C3H mice were  chosen as  the third  strain 
since  they share  the same allele  at the H-2 locus  (H-2  k) as  the CBA host and differ  at the H-2 
locus from the donor A  skin homograft (H-2~). 
In a final  group "immune" serum  s  was obtained from 66 CBA and A mice on the 9th day 
3  Obtained from Mlllipore Filter  Corporation, Bedford,  Massachusetts. 
4  Obtained from Winthrop Laboratories,  New York. 
5  An average of 0.33 ml of serum obtained from each sensitized  mouse. 1086  TRANSPLANTATION  IMMUNITY 
after grafting by terminal bleeding of the donors for the millipore experiments. The serum 
was then separated from the whole blood and in 4 animals (2 A and 2 CBA) 1.67 ml of this 
serum was administered intraperitoneally  2 days after  skin grafting.  In addition,  another 
group of 4 mice was given dally intraperitoneal injections of 0.67 ml of immune serum from 
the day of grafting to biopsy on the 6th day after grafting; thus each one received a total of 
4.0 ml. 
The test skin homografts on all recipient mice were scored by gross and microscopic ex- 
amination. When the gross and microscopic score did not correspond (15 per cent of readings), 
the microscopic appearance determined the final category of the graft site. Tests grafts were 
classified in one of three categories: (a) complete rejection or more than 90 per cent destruction 
of the transplanted  skin; (b) no rejection or less than 10 per cent necrosis of the test graft; 
and (c) partial rejection or necrosis, which included from 10 per cent to 90 per cent necrosis 
of the homograft. The test  skin homografts were removed with 6 days of placement. This 
time interval was chosen since it has been shown that with exchange skin grafts between A 
and CBA mice the MST  s of second set grafts is 6 days and that of first set skin grafts is 10 
TABLE II 
Passive Transfer of Labded Ceils Sensitized to Skin Grafts 
Mice 




Strain  ...  Number 
A  21  6  11  4  1 
CBA  25  1  12  12  8 
Totals  ....  46  7  23  16  9* 
* Represents a total of 27 labeled cells found in 412 autoradiographs. 
No. of graft  sites 
with labeled  cells 
to 11 days (5). Therefore, all grafts which showed partial or complete rejection within 6 days 
after  grafting  were classified as  accelerated rejections. 
I.  Tritiated  Lymphoid  Cells.--The  transfer  of  sensitized labeled lymphoid 
cells to  isologous hosts  resulted in macroscopic and microscopic evidence of 
accelerated homograft rejection in 39  of 46 recipient mice  (Table II).  16  of 
these were complete rejections and 23 exhibited varying degrees of destruction. 
Despite effective passive transfer of homograft immunity  and a 33 percent label 
of the transferred cells, only nine graft sites  7 disclosed the presence of a  total of 
27 labeled cells in 412 autoradiographs. 
The length of time the graft was in place, the length of time the transferred 
cells were in the recipient, the length of time that  transferred cells and test 
homografts were present together in the host,  the route and number of cells 
transferred, were variables that did not affect the small number of labeled sensi- 
tized cells that was found in the test graft site (Fig. 1). 
s  Median survival  time. 
7  Skin graft biopsy sites  included donor skin and host bed. JOHN  S.  NAJARIAN AND  JOSEPH  D.  ~ELDMAN  1087 
The effectiveness of passive transfer of transplantation immunity, however, 
was influenced by some of the technical manipulations listed above (Fig. 1). It 
was observed that the homograft usually had to be in residence for 2 days before 
rejection could be demonstrated. 5 of the 7 grafts in Table II showing no rejec- 
tion were biopsied within 24 hours after grafting and the remaining two grafts 
were biopsied within 48 hours after grafting. Although 2 days were required for 
the onset of rejection, complete graft rejection was evident in 10 of 19 grafts bi- 
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FIG. 1. Relationship of time of biopsy to transfer of labeled cells and skin homograft fol- 
lowing passive transfer of transplantation  immunity. 
opsied after 72 hours residence and the remaining nine showed greater than 50 
per cent destruction. Route of administration of sensitized cells also influenced 
the time of onset of rejection. When the cells were given intravenously,  beginning 
rejection could be seen in 2-day-old grafts as early as 24 hours after cell transfer. 
However, when the  intraperitoneal route was  employed (all CBA mice), the 
earliest signs  of rejection  did not appear  until 48  hours  after cell transfer. 
Finally, it was learned that at least two lymphoid equivalents were necessary to 
transfer transplantation immunity in this system. The effect of increasing doses 
up to six lymphoid equivalents (1.2  X  109 cells)  gave a  more accelerated re- 
sponse at the expense of a higher mortality rate and no appreciable quantitative 
or qualitative change in the morphology of the rejection siste. 1088  TRANSPLANTATION  IM:MLrNIT¥ 
The labeled cells appeared to be mature, small- and medium-sized lympho- 
cytes. 26 of the 27 ceils were present in the host's graft bed and the remaining 
labeled cell was present in the graft itself. 18 of the 27 labeled ceils were found in 
2 animals,  10 in an A mouse, and 8 in a  CBA mouse. However, there was no 
common denominator between  these  two  chance findings  since  the  route of 
injection and the relationship of cell transfer to graft biopsy were different in the 
2 recipients. 
The success of labeling and transferring the ceils was measured by the ease of 
finding labeled cells in the lymph nodes and spleens of the recipients for as long 
as  7 days after cell transfer. Other non-lymphoid parenchymal organs rarely 
showed a labded cell 24 hours after cell transfer. In one animal which died 4 
minutes  after intravenous injection of labeled  cells,  the  tritiated  ceils could 
be found abundantly in the lung and liver, and to a lesser degree, in the kidney, 
but not in the spleen and lymph nodes. 
In the 6 mice in which labeled lymph node fragments were placed subcuta- 
neously around the skin homografts,  there was partial rejection of the grafts 
within 2 days. However, the process of rejection remained partial and was not 
complete even at the 6th post-graft day. The areas of partial rejection usually 
corresponded to the areas of the graft in proximity to the sensitized lymph node 
fragments. Labeled ceils could be identified readily in the lymph node fragments 
but were not present in any of these graft rejection sites. 
II.  Lymphoid Cells in Millipore Chambers.--Passive transfer of transplanta- 
tion immunity was achieved in a  significant number of recipient mice which 
received sensitized  cells enclosed within  millipore chambers  impermeable  to 
these cells (Table III).  The test homograft was completely destroyed in 6 days 
or less in 31 of 66 instances and in none of 42 control recipients. The proportion 
of partial rejections was about the same in both the experimental and control 
groups. But the extent and severity of the necrosis was much greater in the 
recipients of sensitized cells than in recipients of non-sensitized ceils.  In the 
latter instance (the controls), most of the necrosis was due either to technical 
difficulties or to early primary rejection. No evidence of rejection was seen in 
less than one-sixth of the experimental hosts and in two-thirds of the control 
hosts. 
A comparison of A and CBA strains revealed a difference in the immunologic 
potency of  the  transferred cells.  Sensitized  CBA  cells enclosed in  millipore 
chambers and placed in CBA hosts rejected completely 21 of 30 A homografts 
within 6 days. Sensitized A cells in A hosts rejected completely 10 of 36 CBA 
homografts (Table III). A similar finding was observed in the experiments with 
transfer of labeled sensitized ceils in which  12 of 23  CBA recipients showed 
complete homograft rejection, and only 4 of 18 A recipients showed complete 
homograft destruction (Table II). 
The region of implantation of the millipore chambers influenced rate of rejec- JOHN  S.  NAJARIAN  AND  JOSEPH  D.  YELDMAN  1089 
tion of the homograft. In mice with subcutaneously implanted chambers con- 
taining sensitized cells, there were gross and microscopic signs of rejection by 
the 3rd day after grafting, and rejection was usually complete by the 6th post- 
graft day. In mice with intraperitoneal millipore chambers, the gross appearance 
of all grafts and microscopic appearance of five out of seven biopsies on the 3rd 
post-graft day showed no signs of rejection. However, by the 6th day after 
grafting, all grafts elicited both macroscopic and microscopic stigmata of graft 
rejection. 
TABLE HI 


































* Transfer of non-sensitized  cells  in miUipore  chambers. 
Careful examination of the millipore chambers at autopsy of  the mice re- 
vealed no evidence of perforation of the membranes or separation from the 
lucite rings. Microscopic examination of the chambers disclosed that no ceils 
or parts of cells were traversing the wall. Within the  chambers were  clumps 
and aggregates of viable lymphoid elements and necrotic material. It was not 
possible by microscopic examination to estimate quantitatively the number of 
viable cells  remaining. There  was  no apparent  histologic difference between 
the contents of chambers containing isologous sensitized cells and the contents 
of the  control  chambers  which  contained isologous non-sensitized lymphoid 
cells. 
Cells sensitized against A strain tissues and transferred in miUipore chambers 
into the peritoneum of CBA hosts completely rejected 3 out of 6 A skin grafts 
and had no effect on 6 C3H skin grafts placed on the same CBA recipients. 
Intraperitoneal injection of immune serum given as a single 1.67 ml dose on 
the 2nd day after grafting or as daily 0.67 ml doses for 6 days did not influence 
homograft survival. 1090  TRANSPLANTATION D~UNITY 
DISCUSSI01~ 
This study has demonstrated that sensitized viable lymphoid cells transferred 
transplantation immunity by rejecting specific homografts within 6 days or less 
without apparently infiltrating the graft site. These results were in accord with 
the findings of Mitchison and Dube (6) who, using acriflavine dye as a marker, 
were unable to find labeled sensitized cells at the site of subcutaneously trans- 
ferred SAI tumor cells following passive transfer of the sensitized cells. Despite 
our use of a permanent cellular label such as tritiated thymidine, labeled cells 
could not be demonstrated at the site of rejection when examined as early as 
12 hours after grafting and as late as the 6th post-graft day. Adequate tagging 
was shown by the 33 per cent average labeling of cells seen on smears of the 
transferred suspensions, and persistence of the label could be demonstrated by 
the ease of finding labeled cells in the autoradiographs of spleens and lymph 
nodes taken 7 days after transfer. 
Two explanations may be entertained to explain the results of the  passive 
transfer studies with trifiated sensitized cells. Either the sensitized cells partici- 
pated in the reaction at the graft site but were rapidly destroyed, or the sensi- 
tized  cells  produced a  soluble  product  which  rejected  the  graft directly or 
transferred the sensitivity to host cells. The first possibility of rapid destruction 
of the sensitized cells seemed unlikely since graft sites biopsied at varying time 
intervals from 12 hours to 6 days after cell transfer failed to  disclose  labeled 
cells. In addition, when sensitized labeled lymph node fragments were placed 
subcutaneously around homografts or directly in contact with the graft, daily 
biopsy of these nodes revealed a progressive central necrosis of the fragments 
as would be expected from athrepsia but the outer rim of the fragment remained 
viable, even on the side in juxtaposition to the rejecting graft. 
The series of experiments in which sensitized cells were transferred in milli- 
pore chambers indicated that a soluble product was produced by the sensitized 
cells and this humoral agent could cause rejection of the graft. The question as 
to whether the humoral agent transferred immunity to the host's cells or acted 
directly upon the graft could not be answered by these studies. 
In  this experiment,  transfer of homograft immunity could not be  accom- 
plished with serum from sensitized animals even when given in doses up to 5 
animal equivalents (1.67 ml) in a  single intraperitoneal injection or 4 ml ad- 
ministered at the rate of 0.67 ml daily for 6 days. Humoral antibodies detected 
by hemagglutination (7,  8),  leukocyte agglutination (9,  10), and cytotoxicity 
techniques  (11, 12)  have frequently been demonstrated in  animals rejecting 
tissue or tumor transplants. However, the isoimmune sera of animals rejecting 
tissue homografts have generally been ineffective in passive transfer of trans- 
plantation immunity (5, 13) unless given locally (14, 15) or given systemically 
with application of xylene or bromobenzene locally to increase vascular perme- JOHN  S.  NAJARIAN  AND  JOSEPH  D.  FELDMAN  1091 
ability (14). In view of the results of this study, it would appear that the failure 
to transfer transplantation  immunity with serum might be related to the low 
concentration  of "antibodies"  present in  the sensitized  animal  at any given 
time. In our experiments, apparently ceils in millipore  chambers continuously 
released a humoral agent in sufficient quantity to reject the homograft. 
The  question  arose  as  to  why sensitized  cells  within  miUipore  chambers 
rejected homologous skin grafts in this investigation, in contrast to the reverse 
situation in which homologous tissues within millipore  chambers survived for 
prolonged periods within sensitized  hosts  (16, 17). Two explanations for this 
apparent paradox may be considered.  The first is the demonstration of a slow 
transfer of antibody from the vascular tree to peritoneal cavity as compared 
to rapid absorption of antibody from the peritoneal cavity to the blood (18). 
Secondly, Amos has recently shown that  complement traverses  the millipore 
membranes with ditficulty and  he was unable to show titers  of complement 
within the chambers above one-tenth those found in the serum (19). Therefore, 
inadequate  quantities  of  complement  and  "antibody"  within  the  millipore 
chambers might explain  why homologous  tissues  within the chambers have a 
prolonged  survival in  sensitized  hosts  whereas homologous  skin  grafts  were 
readily rejected when sensitized  cells were enclosed  within millipore chambers. 
More recently, Gabourel has reported that growth of L-fibroblasts within milli- 
pore chambers  was inhibited  when  the  chambers  were  placed in  "hyperim- 
munized" mice (20). 
Finally,  these results  were distinctly different from those  observed in  the 
transfer of tuberculin sensitivity in which the  specifically sensitized  cells were 
found in significant  numbers in the site tested with specific antigen  (3)  and 
were ineffective when enclosed in millipore chambers. However, the test system 
used for the tuberculin and homograft reactions were accomplished in 2 different 
species,  guinea pigs  and mice,  respectively. To verify this difference,  experi- 
ments  with  transfer  of  transplantation  immunity  using  tritiated  sensitized 
cells are currently being investigated in inbred guinea pigs. 
SUMMARy 
Passive transfer of tritiated  thymidine labeled lymphoid cells sensitized  to 
homologous  tissues into non-sensitized  isologous hosts resulted in accelerated 
rejection of homologous skin grafts in the recipients.  Despite 33 per cent label 
of the suspension,  only rare labeled sensitized  lymphoid cells  could be found 
at the site of rejection. 
Passive transfer of sensitized  lymphoid cells in millipore chambers implanted 
subcutaneously or intraperitoneally  in non-sensitized  isologous hosts resulted 
in accelerated homograft rejection in the recipients.  Transfer of transplantation 
immunity could not be accomplished  with serum from sensitized  hosts. 1092  TRANSPLANTATION IMMUNITY 
The rejection of homologous tissues  without  the  physical presence of the 
sensitized cell at the graft site suggested that a humoral agent produced by the 
cell was capable of rejecting the homograft. 
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